Braskem Faces Dilution Risk as Petrochemical Spreads Remain Depressed, BTG Says

<p>Debt-to-equity conversion could ease leverage but would require a multibillion-dollar Petrobras injection and cut dividends — keeping uncertainty high.</p>

Braskem tariff extension

By Brazil Stock Guide — Braskem S.A. (B3: BRKM5, NYSE: BAK) remains under heavy pressure, according to a BTG Pactual report. With petrochemical spreads still falling and financial expenses eroding value, the bank notes the company may need to consider capital-raising alternatives, including a debt-to-equity swap.

BTG modeled a scenario in which 25% of Braskem’s debt ($1.7 billion) is converted into equity. In that case, Petrobras (B3: PETR3; PETR4, NYSE: PBR) would have to inject an equal amount to preserve up to 49% ownership, avoiding full consolidation of the petrochemical producer on its balance sheet. Leverage would fall from 10.6x to 2.6x net debt/EBITDA by 2026, but the move would cause about 75% dilution for existing shareholders. For Petrobras, the impact would be a 0.8 percentage-point cut in dividend yield, to roughly 8.2%.

Liquidity and Credit Risk

Braskem’s most critical maturity comes in 2028, when it will need to refinance its RCF (Revolving Credit Facility, a syndicated credit line that companies can draw, repay, and reborrow to manage short-term liquidity) amid successive rating downgrades. While its Mexican subsidiary Braskem Idesa is non-recourse, the relief is limited at the consolidated level.

The bank stressed that Braskem has already hired financial and legal advisers, a sign that alternatives such as convertibles or collateralized loans remain under consideration. For investors, the short-term equation is survival versus dilution. Without a recovery in spreads or a structured capital injection, pressure on Braskem’s balance sheet is likely to persist.


Clear insights on Brazilian equities

Join portfolio managers and investors who get our curated analysis on Latin America’s largest economy.

Advertisement